Urotec Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 1.78 M
- Revenue Growth 1833.83%
- Profit Growth 514.68%
- Ebitda 1294.76%
- Net Worth 95.92%
- Total Assets 639.16%
About Urotec Solutions
Urotec Solutions Private Limited (USPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 October 2017 (Seven years and four months 20 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.78 M.
Jaya Mistry and Prasant Sharma serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304MH2017PTC300444
- Company No.
300444
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Oct 2017
- Date of AGM
27 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Urotec Solutions?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaya Mistry  | Director | 01-May-2023 | Current |
| Prasant Sharma | Director | 01-May-2023 | Current |
Financial Performance of Urotec Solutions.
Urotec Solutions Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 1833.83% increase. The company also saw a substantial improvement in profitability, with a 514.68% increase in profit. The company's net worth Soared by an impressive increase of 95.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Urotec Solutions?
In 2019, Urotec Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.78 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2020 | Others | ₹0.28 M | Open |
| 14 Mar 2018 | Others | ₹1.50 M | Open |
How Many Employees Work at Urotec Solutions?
Unlock and access historical data on people associated with Urotec Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Urotec Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Urotec Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
